Congenica is a digital health company enabling the rapid analysis and interpretation of genomic data empowering researchers and clinicians to provide life-changing answers for patients and their families. Born out of pioneering research from the Wellcome Sanger Institute and the UK NHS, Congenica’s Clinical Decision Support software for the analysis, interpretation and reporting of clinical NGS data is used world-wide to determine the genetic etiology of a patient’s condition.
Congenica’s Genomic Insights and Solutions for Pharma leverage our unique bioinformatic capabilities and deep expertise in precision diagnostics to elucidate the root cause of disease biology and drive development of new precision medicines. Using proprietary methodologies for targeted gene and variant analysis, we create bespoke deliverables for each client, translating genomic data into valuable insights that de-risk discovery research, clinical development and post-market surveillance of approved therapeutics.
website